JPRN-C000000071已完成未知
Phase II Study of Amrubicin in Patients with Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy - Phase II Study of Amrubicin in Patients with Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The exclusion criteria consisted of pulmonary fibrosis or interstitial pneumonitis with symptoms or apparent abnormalities on chest X-ray, massive pleural effusion, pericardial effusion, or ascites, pregnancy, lactation, symptomatic brain metastases, active concurrent malignancies, severe drug allergies, myocardial infarction, severe heart disease, severe superior vena cava syndrome, uncontrollable diabetes mellitus, severe infection, or active peptic ulcer. Patients who have prior receive amrubicin and other anthracycline drugs were excluded, too.
研究者
相似试验
未知
不适用
A phase II study of Amrubicin in patients with previously treated small cell lung cancersmall cell lung cancerJPRN-C000000141Kinki University School of Medicine30
已完成
2 期
Phase II study of weekly amrubicin in patients with refractory or relapsed non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000002570ational Hospital Organization Nagoya Medical Center43
已完成
2 期
Phase 2 Study of Amrubicin for patients with recurrent advanced squamous cell lung cancer after first line treatment.Recurrent squamous cell lung cancerJPRN-UMIN000006270Kansai Medical University Hirakata Hospital40
已完成
2 期
Phase II study of amrubicin for previously treated advanced non-small cell lung cancerRecurrent non-small cell lung cancerJPRN-UMIN000001751Gunma University Hospital35
已完成
1 期
PhaseI Study of Amrubicin for Previously Treated Small Cell Lung CancerFor patients with recurrent or relapsed small cell lung cancerJPRN-C000000177Kobe City General Hospital18